Kirk Perry serves as the Chief Executive Officer of Kenvue Inc., the world's largest pure-play consumer health company, which was spun off from Johnson & Johnson in 2023. With over three decades of leadership experience, Perry began his career at Procter & Gamble (P&G) in 1987, rising through the ranks in sales, marketing, and general management roles across oral care, baby care, and health care divisions. He held key positions such as President of P&G's North America business, where he drove significant revenue growth and market share gains for iconic brands like Pampers and Oral-B, and Group President for Global Health Care, overseeing a portfolio that generated billions in annual sales. Perry's strategic vision and operational expertise were instrumental in the successful separation and IPO of Kenvue, leading the company through its transition to independence while maintaining strong performance amid market challenges. Under his leadership, Kenvue has focused on innovation, sustainability, and expanding its portfolio of trusted brands, including Tylenol, Neutrogena, Listerine, and Band-Aid, achieving robust growth in self-care and skin health & beauty segments. His tenure has emphasized consumer-centric strategies, supply chain resilience, and long-term value creation for stakeholders. As CEO, Perry continues to steer Kenvue toward sustainable growth, leveraging his deep industry knowledge to navigate evolving consumer needs and regulatory landscapes. A recognized leader in consumer goods, he has been honored with awards such as being named one of Fortune's Most Powerful People in Business and serves on the boards of several prominent organizations, advocating for health equity and corporate responsibility.